Additionally, recent evidence suggested that HIF-1α inhibition was able to alleviate tumor immunosuppression induced by hypoxia and sensitize tumor’s response to immunotherapy in lung cancer (65). This evidence concerns the gene HIF1A and lung carcinoma.